Literature DB >> 18723451

Causes and metabolic consequences of Fatty liver.

Norbert Stefan1, Konstantinos Kantartzis, Hans-Ulrich Häring.   

Abstract

Type 2 diabetes and cardiovascular disease represent a serious threat to the health of the population worldwide. Although overall adiposity and particularly visceral adiposity are established risk factors for these diseases, in the recent years fatty liver emerged as an additional and independent factor. However, the pathophysiology of fat accumulation in the liver and the cross-talk of fatty liver with other tissues involved in metabolism in humans are not fully understood. Here we discuss the mechanisms involved in the pathogenesis of hepatic fat accumulation, particularly the roles of body fat distribution, nutrition, exercise, genetics, and gene-environment interaction. Furthermore, the effects of fatty liver on glucose and lipid metabolism, specifically via induction of subclinical inflammation and secretion of humoral factors, are highlighted. Finally, new aspects regarding the dissociation of fatty liver and insulin resistance are addressed.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18723451     DOI: 10.1210/er.2008-0009

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  186 in total

Review 1.  [Obesity: ectopic fat distribution and the heart].

Authors:  Dirk Müller-Wieland; Birgit Knebel; Jutta Haas; Martin Merkel; Jörg Kotzka
Journal:  Herz       Date:  2010-05       Impact factor: 1.443

2.  Protective effects of farnesoid X receptor (FXR) on hepatic lipid accumulation are mediated by hepatic FXR and independent of intestinal FGF15 signal.

Authors:  Johannes Schmitt; Bo Kong; Grace L Guo; Andreas Geier; Bruno Stieger; Oliver Tschopp; Simon M Schultze; Monika Rau; Achim Weber; Beat Müllhaupt
Journal:  Liver Int       Date:  2014-02-07       Impact factor: 5.828

3.  Sonographic Features of the Liver Among Females with Type 2 Diabetes.

Authors:  Bárbara L Riestra-Candelaria; Loida A González-Rodríguez; Wilma Rodriguez-Mojica; Luis E Vázquez-Quiñones; Juan Carlos Jorge
Journal:  J Diagn Med Sonogr       Date:  2019-03-08

4.  Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study.

Authors:  Sarah R Preis; Joseph M Massaro; Sander J Robins; Udo Hoffmann; Ramachandran S Vasan; Thomas Irlbeck; James B Meigs; Patrice Sutherland; Ralph B D'Agostino; Christopher J O'Donnell; Caroline S Fox
Journal:  Obesity (Silver Spring)       Date:  2010-03-25       Impact factor: 5.002

Review 5.  Inflammation and fibrogenesis in steatohepatitis.

Authors:  Hideki Fujii; Norifumi Kawada
Journal:  J Gastroenterol       Date:  2012-02-07       Impact factor: 7.527

6.  Phenotypic comparison of common mouse strains developing high-fat diet-induced hepatosteatosis.

Authors:  Melanie Kahle; Marion Horsch; Barbara Fridrich; Anett Seelig; Jürgen Schultheiß; Jörn Leonhardt; Martin Irmler; Johannes Beckers; Birgit Rathkolb; Eckhard Wolf; Nicole Franke; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Susanne Neschen
Journal:  Mol Metab       Date:  2013-08-03       Impact factor: 7.422

7.  Comparison of fatty liver index with noninvasive methods for steatosis detection and quantification.

Authors:  Shira Zelber-Sagi; Muriel Webb; Nimer Assy; Laurie Blendis; Hanny Yeshua; Moshe Leshno; Vlad Ratziu; Zamir Halpern; Ran Oren; Erwin Santo
Journal:  World J Gastroenterol       Date:  2013-01-07       Impact factor: 5.742

8.  Multiple short bouts of exercise over 12-h period reduce glucose excursions more than an energy-matched single bout of exercise.

Authors:  Michael Holmstrup; Timothy Fairchild; Stefan Keslacy; Ruth Weinstock; Jill Kanaley
Journal:  Metabolism       Date:  2013-12-14       Impact factor: 8.694

9.  Increased lipid synthesis and decreased β-oxidation in the liver of SHR/NDmcr-cp (cp/cp) rats, an animal model of metabolic syndrome.

Authors:  Shizuyo Tanaka; Tohru Yamazaki; Satoshi Asano; Atsushi Mitsumoto; Daisuke Kobayashi; Naomi Kudo; Yoichi Kawashima
Journal:  Lipids       Date:  2013-09-18       Impact factor: 1.880

10.  Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.

Authors:  Wojciech G Garbacz; Peipei Lu; Tricia M Miller; Samuel M Poloyac; Nicholas S Eyre; Graham Mayrhofer; Meishu Xu; Songrong Ren; Wen Xie
Journal:  Mol Cell Biol       Date:  2016-10-13       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.